Healome Therapeutics raises €186K Pre-Seed round
20 October 2021· Birmingham, United Kingdom· health, biotech, materials, b2b, deep_hardware
The pre-seed funding supported the company's initial spin-out from the University of Birmingham to commercially deploy its 'pro-healing' ocular platform.
Investors
LeadSFC Capital
About Healome Therapeutics
Stage
Series A
Headquarters
Birmingham, United Kingdom
Founded
2021
Team Size
1–5
Sectors
healthbiotechmaterialsb2bdeep_hardware